500 back pain patients enrolled in new treatment registry
Knowledge-focused
Ongoing
This study is a registry that follows 500 adults with disc-related back pain who received an injection of VIA Disc NP. Researchers will track changes in pain, disability, satisfaction, and pain medication use for up to 12 months. The goal is to observe real-world outcomes and pat…
Sponsor: VIVEX Biologics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC